Use of the International Prognostic Index and the Tumor Score to Detect Poor-Risk Patients with Primary Mediastinal Large B-Cell Lymphoma: A Study of 37 Previously Untreated Patients

References

• Liechtenstein K., Levine A., Taylor C. R., Boswell W., Rossman S., Feinstein D. I., Lukes R. J. Primary mediastinal lymphoma in adults. American Journal of Medicine 1980; 68: 509–514
   PubMed Web of Science ®Google Scholar
• Lamarre L., Jacobson J. O., Aisenberg A. C., Harris N. L. Primary large cell lymphoma of the mediastinum: A histologic and immunophenotypic study of 29 cases. American Journal Surgical Pathology 1989; 13(9)730–739
   PubMed Web of Science ®Google Scholar
• Perrone T., Frizzera G., Rosai J. Mediastinal diffuse large cell lymphoma with sclerosis: A clinicopathologic study of 60 cases. American Journal Surgical Pathology 1986; 10(3)176–191
   PubMed Web of Science ®Google Scholar
• Miller J. B., Variakojis D., Bitran J. D., Sweet D. L., Kinzie J. J., Golomb H. M., Ultmann J. E. Diffuse histiocytic lymphoma with sclerosis: A clinicopathologic entity frequently causing superior venacaval obstruction. Cancer 1981; 47: 748–756
   PubMed Web of Science ®Google Scholar
• Addis B. J., Isaacson P. G. Large cell lymphoma of the mediastinum: A B-cell tumor of probable thymic origin. Histopathology 1985; 10: 379–390
   Web of Science ®Google Scholar
• Möller P., Moldenhauer G., Momburg F., Lammler B., Erberlein-Gonska M., Kiesel S., Dorken B. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B-cell differentiation. Blood 1987; 69(4)1087–1095
   PubMed Web of Science ®Google Scholar
• Hofmann W. J., Momburg F., Möller P., Otto H. F. Intra- and extrathymic B-cells in physiologic and pathologic conditions: Immunohistochemical study on normal thymus and lymphofollicular hyperplasia of the thymus. Virchows Archiv A Pathol Anat Histopathol 1988; 412: 431–442
   PubMedGoogle Scholar
• Scarpa A., Bonetti F., Menestrina F., Menegazzi M., Chilosi M., Lestani M., Bovolenta C., Zamboni G., Fiore-Donati L. Mediastinal large cell lymphoma with sclerosis: Genotypic analysis establishes its B nature. Virchows Arch A 1987; 412: 17–21
   Web of Science ®Google Scholar
• Isaacson P. G., Norton A. J., Addis B. J. The human thymus contains a novel population of B-lymphocytes. Lancet 1987; 1488–1490
   PubMed Web of Science ®Google Scholar
• Joos S., Otano-Joos M., Ziegler S., Brudelein S., du Manoir S., Bentz M., Moller P., Lichter P. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996; 87(4)1571–1578
   PubMed Web of Science ®Google Scholar
• Jacobson J. O., Aisenberg A. C., Lamarre L., Willet C. G., Linggood R. M., Miketic L. M., Harris N. L. Mediastinal large cell lymphoma: An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 1988; 62: 1893–1898
   PubMed Web of Science ®Google Scholar
• Todeschini G., Ambrosetti A., Meneghini V., Pizzolo G., Menestrina F., Chilosi M., Benedetti F., Veneri D., Cetto G. L., Perona G. Mediastinal large B-cell lymphoma with sclerosis: A clinical study of 21 patients. Journal Clinical Oncology 1990; 8(5)804–808
   PubMed Web of Science ®Google Scholar
• Al-Sharabati M., Chittal S., Duga-Neulat I., Mazerolles C., Brousset P. Primary anterior mediastinal B-cell lymphoma: A clinicopathologic study of 16 cases. Cancer 1991; 647: 2579–2587
   Web of Science ®Google Scholar
• Trump D. I., Mann R. B. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement: A poor prognostic subset of patients with non-Hodgkin's lymphomas. Cancer 1982; 50: 277–282
   PubMed Web of Science ®Google Scholar
• Bertini M., Orsucci L., Vitolo U., Levis A., Todeschini G., Meneghini V., Novero D., Tarella C., Gallo E., Luxi G., Pizzuti M., Novarino A., Urgesi A., Resegotti L. Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Annals Oncology 1991; 2: 733–737
   PubMed Web of Science ®Google Scholar
• Kirn D., Mauch P., Shaffer K., Pinkus G., Shipp M. A., Kaplan W. D., Tung N., Wheeler C., Beard C. J., Canellos G. P., Shulman L. N. Large cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patients. Journal Clinical Oncology 1993; 11: 1336–1343
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphomas. New England Journal Medicine 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Rodriguez J., Cabanillas F., McLaughlin P., Swan F., Rodriguez M., Hagemeister F., Romaguera J. A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the “tumor score”. Annals Oncology 1992; 3: 711–717
   PubMed Web of Science ®Google Scholar
• Rodriguez J., Pugh W. C., Romaguera J. E., Luthra R., Hagemeister F. B., McLaughlin P., Rodriguez M. A., Swan F., Cabanillas F. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low b2-microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase. Annals of Oncology 1994; 5: 847–849
   PubMed Web of Science ®Google Scholar
• Swan F., Velasquez W. S., Tucker S., Redman J. R., Rodriguez M. A., McLaughlin P., Hagemeister F. B., Cabanillas F. A new serologic staging system for large-cell lymphomas based on initial b2-microglobulin and lactate dehydrogenase levels. Journal Clinical Oncology 1989; 7(10)1518–1527
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K. C., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermellink H. K., Pileri S. A., Pins M. A., Ralfkiaer E., Warnke R. A. A revised european-american classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Hsu S. M., Raines L., Fanger H. Use of avidinbiotin-peroxidase complex (ABC) and immunoperoxidase technique: Comparison between ABC and unlabeled antibody (PAP) procedures. Journal Histochemistry Cytochemistry 1981; 29: 577–580
   PubMed Web of Science ®Google Scholar
• Jagannath S., Velasquez W. S., Tucker S. L., Fuller L. M., McLaughlin P. W., Manning J. T., North L. B., Cabanillas F. Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma. Journal Clinical Oncology 1986; 4: 859–865
   PubMed Web of Science ®Google Scholar
• Rodriguez V., Cabanillas F., Burgess M. A., McKelvey E. M., Valdivieso M., Bodey G. P. Combination chemotherapy “CHOP-Bleo” in advanced (non-Hodgkin) malignant lymphoma. Blood 1977; 49: 325–333
   PubMed Web of Science ®Google Scholar
• Cabanillas F., McLaughlin P., Hagemeister F. B., Swan F., Jr., Rodriguez M. A., Romaguera J., Majlis A., Jendiroba D., Rodriguez J. Improvement in survival and disease free survival of intermediate grade and immunoblastic lymphomas treated with the novel ATT regimen. Proceedings ASCO 1994; 13: 338, (abstr.: 1323)
   Google Scholar
• Velasquez W., Hagemeister F., Fuller L. M., Allen P. K., Tucker S. I., Swan F., Rodriguez M. A., Hagemeister F. B., Cabanillas F. Intermediate grade lymphomas treated with cyclophosphamide- doxorubicin-vincristine-prednisone and bleomycin (CHOP-Bleo) alternated with cyclophosphamide- methotrexate-etoposide-dexamethasone (Cmed). Application of prognostic models to data analysis. Cancer 1994; 73(9)2408–2416
   PubMed Web of Science ®Google Scholar
• Klimo P., Connors J. M. MACOP-B Chemotherapy for the treatment of diffuse large-cell lymphoma. Annals of Internal Medicine 1985; 102: 596–602
   PubMed Web of Science ®Google Scholar
• Swan F., Velasquez W., Fuller L., Rodriguez A., MacLaughlin P., Romaguera J., Redman J., Hagemeister F., Cabanillas F. Successful outcome of patients (pts) with good risk large cell lymphoma (LCL) with a shortened schedule of treatment (RX). Proc ASCO 1991; 10: 273
   Google Scholar
• Peto R., Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc 1972; 35: 185–207
   Google Scholar
• Kaplan E. L., Meier P. Non-parametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457–481
   Web of Science ®Google Scholar
• Cresswell P., Springer T., Strominger J. L., et al. Immunological identity of the small subunit of HLA antigens and beta 2-microglobulin and its turnover on the cell membrane. Proceedings of the National Academy Science of USA 1974; 71: 2123–2127
   PubMed Web of Science ®Google Scholar
• Fisher R. I., Gaynor E. R., Dahlberg S., Martin M. O., Grogan T. M., Mize E. M., Glick J. H., Coltman C. A., Jr., Miller T. P. Comparison of standard regimen (Chop) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New England Journal Medicine 1993; 328: 1002–1006
   PubMed Web of Science ®Google Scholar
• Glick G. H., Kine K., Earle J., O'Connell M. J. An ECOG randomized phase III trial of Chop vs. Chop + radiotherapy (XRT) for intermediate grade early stage non-Hodgkin's lymphoma (NHL). Proceedings ASCO. 1995; 14: 391, (abstr 1221)
   Google Scholar